CU Anschutz Skaggs School of Pharmacy and Pharmaceutical Sciences professor Toby Trujillo, PharmD, has been chosen as the president-elect of the American College of Clinical Pharmacy (ACCP). The three-year commitment begins as president-elect, president, and past-president, with each position being a one-year term. Dr. Trujillo will begin his term as president-elect after the 2025 ACCP Annual Meeting in October and will assume the presidency in October 2026. As president, he will serve as chair of the Board of Regents which guides college programs and activities. ACCP’s purpose is to improve human health by extending the frontiers of clinical pharmacy through strategic initiatives, partnerships, collaborations, and alliances.
“My career has focused on developing and expanding new roles for pharmacists in order to enhance care provided to patients which aligns with the mission of ACCP,” Trujillo said. “To be able to give back to the organization in this capacity means a lot to me.”
Career
Trujillo’s career began when he received his Doctor of Pharmacy degree from the University of California, San Francisco (UCSF), and completed a residency in pharmacy practice.
“I got to see the roles that pharmacists at UCSF had developed for themselves, and then I was able to continue to do that in my own career and for other pharmacists,” he said.
In addition to teaching PharmD courses, Trujillo serves as a clinical pharmacy specialist in cardiovascular pharmacotherapy and anticoagulation at UCHealth University of Colorado Hospital. In his current role, he is involved in the stewardship of antithrombotic medications across the UC Health System, which includes serving as co-chair of the Anticoagulation Stewardship Committee.
Trujillo has been an active member of ACCP since 1996, serving on the Board of Regents and the Pharmacotherapy Publications Inc. Board of Directors from 2016 to 2019. He has also served on numerous ACCP committees; as an abstract reviewer, poster judge, and moderator; as a reviewer for Pharmacotherapy; and as an author and reviewer for specialty certification programs.
“To be able to come back in the role of president is an honor, to be selected by my peers... I don’t think I can put into words how much it means to me,” he said.
“ACCP has a pretty central role in advancing clinical pharmacy, and I think it has done a fantastic job in the last decade of supporting clinical pharmacists, no matter where they practice. The organization is there to advocate for them at a state and federal level, to provide education and to provide the ability for pharmacists to enhance their skills, and to be able to collaborate with other colleagues to be creative and think of new ideas and advance their practice.”
ACCP Leadership
Trujillo views ACCP’s core role and mission necessitating a collaborative partnership with other leading pharmacists' organizations.
“It means really collaborating in a shared partnership to accomplish that mission. I see us as a key piece in a bigger picture,” he said.
Looking ahead, Trujillo says he’s eager to help shape that “bigger picture,” drawing on nearly three decades of experience as a clinician, educator, and advocate.
“As president, I want to make sure ACCP continues to be the place where clinical pharmacists find their voice and their future,” he said. “That means strengthening our connections with other professional groups, supporting innovative practice models, and ensuring that pharmacists are recognized as essential members of every patient-care team.”
When Trujillo officially assumes the ACCP presidency in 2026, he’ll do so with the same commitment that has defined his career—advancing clinical pharmacy and improving the lives of patients everywhere.
.png)
